Welcome to our dedicated page for American Vanguard news (Ticker: AVD), a resource for investors and traders seeking the latest updates and insights on American Vanguard stock.
American Vanguard Corporation (AVD) specializes in developing agricultural and specialty chemical solutions for crop protection and health applications. This page serves as the definitive source for all official news and press releases related to the company’s operations, financial performance, and market developments.
Investors and stakeholders will find timely updates including earnings reports, product launch announcements, strategic partnerships, and regulatory milestones. Our curated collection ensures access to primary-source information critical for informed decision-making, with content verified for accuracy and relevance.
Regular updates cover AVD’s innovations in chemical formulations, distribution network expansions, and sustainability initiatives within the agrochemical sector. Bookmark this page to monitor the company’s progress in addressing evolving agricultural challenges through science-driven solutions.
American Vanguard Corporation (NYSE: AVD) reported a robust financial performance for the year ending December 31, 2022, with net sales reaching $610 million, a 9% increase from 2021. Net income rose by 47% to $27.4 million, while earnings per diluted share surged 51% to $0.92. The company also achieved an adjusted EBITDA of $73.1 million, a 15% growth year-over-year. The U.S. Crop business benefited from high commodity prices, leading to increased sales in various agricultural sectors. Looking ahead, AVD aims for 2023 net sales between $655M and $685M and continues to focus on strategic growth initiatives.
American Vanguard Corporation (NYSE: AVD) will report its fourth-quarter financial results for the period ending December 31, 2022, on March 13, 2023, after market close. A conference call will be held at 4:30 p.m. ET to discuss the results, featuring CEO Eric Wintemute and other executives. Interested participants should call 201-493-6744 and join 10 minutes early. Additionally, the call will be webcast live on the company's website. American Vanguard is a diversified company focused on crop protection and nutrition, and is part of major stock indexes, including Russell 2000 and S&P Small Cap 600.
American Vanguard Corporation (NYSE: AVD) reported preliminary financial results for the fiscal year ending December 31, 2022. The company experienced a shortfall in Q4 due to supply chain issues affecting the production of its top-selling insecticide, Aztec®, resulting in net sales comparable to Q4 2021. Despite this, full-year adjusted EBITDA is projected between
AMGUARD Environmental Technologies, a division of American Vanguard Corporation (NYSE:AVD), has acquired the product and trademark assets of American Bio-Systems, known for its microbial cleaning products, BioMop-Plus® and DrainGel®. With over 20 years in the industry, these products address persistent drain issues in food-service and hospitality sectors. CEO Shayne M. Wetherall emphasizes that these solutions improve sanitation by digesting organic waste, differentiating them from conventional cleaning products. The acquisition aligns with AMGUARD's strategy to enhance its portfolio of biological solutions for commercial pest control.
American Vanguard Corporation (NYSE: AVD) has launched BioWake™, a dual-use biological seed lubricant, enhancing seed flow and nutrient uptake for corn and soybean farmers. This innovative product, part of AMVAC's GreenSolutions™ portfolio, combines microbial inoculants and soy protein for effective planting. Trials indicate significant yield increases. BioWake will be available for purchase in the 2023 growing season, offering farmers a cleaner alternative to traditional lubricants.
American Vanguard Corporation (NYSE: AVD) has declared a cash dividend of $0.03 per share, reflecting a 20% increase from previous quarters. Shareholders of record as of December 28, 2022, will receive the dividend on January 11, 2023. Chairman Eric W. Wintemute highlighted strong financial performance in 2022 and a positive outlook for 2023 as key factors for the increase. This decision underscores the Board's confidence in the company's financial stability and growth prospects, with past dividends of $0.095 in 2022 and $0.08 in 2021.
American Vanguard Corporation (NYSE: AVD) reported strong financial results for Q3 and the first nine months of 2022. Net sales increased by 3.4% in Q3 to $152 million, while net income rose 21.8% to $6.7 million. For the nine-month period, net sales reached $450 million (13.1% growth) and net income surged 71.5% to $23.5 million. The company attributed growth to high crop prices and strong international sales, particularly in Brazil and Mexico. However, domestic non-crop business faced challenges due to decreased consumer spending.
American Vanguard Corporation (NYSE: AVD) has successfully registered its Counter® insecticide for soybean use in Brazil, the largest agricultural market globally. This soil insecticide effectively combats yield-damaging nematodes and can be integrated with other pest control products. CEO Vitor Cunha noted the product's technical performance and yield enhancement, potentially increasing farmer profitability. Chairman Eric Wintemute emphasized the importance of expanding Counter's international market presence, highlighting its role in the company's precision application technology.
American Vanguard Corporation (NYSE: AVD) announced it will report its financial results for Q3 ended September 30, 2022, on November 8, 2022, after market close. A conference call will follow at 4:30 PM ET to discuss operating performance, featuring CEO Eric Wintemute, COO Bob Trogele, and CFO David T. Johnson. Interested parties can join via phone or live webcast. American Vanguard specializes in crop protection and nutrition, pest control, and is part of Russell 2000® and S&P Small Cap 600 Indexes.
American Vanguard Corporation (NYSE: AVD) has partnered with NewLeaf Symbiotics to enhance its GreenSolutions™ biological product portfolio for the North American crop market starting in 2023. This collaboration will leverage the strengths of both companies to expand current product applications and foster new product development. AMVAC recently achieved a milestone of over 1.2 million acres applied with its GreenSolutions, marking significant growth in the biologicals segment. The partnership aims to improve market penetration and provide innovative solutions for North American farmers.
FAQ
What is the current stock price of American Vanguard (AVD)?
What is the market cap of American Vanguard (AVD)?
